The Evaluation and Management of Patients With Acute Chest Pain in China

NCT ID: NCT02384863

Last Updated: 2015-03-10

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

18000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2014-10-31

Study Completion Date

2016-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to describe the characteristics, evaluation, management and outcomes of acute chest pain, and to provide opportunities for future initiatives to improve the emergency care for patients experiencing acute chest pain in China.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Chest Pain Acute Coronary Syndrome

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Acute chest pain(pain in the area inferior to the clavicle, superior to the rib arch, and anterior to the bilateral posterior axillary line);
* Possible Acute Coronary Syndrome;
* Symptoms occurring within last 24 hours;
* Informed consent from patient or next of kin.

Exclusion Criteria

* Arrhythmia or heart failure not cause by myocardial ischemia;
* Confirmed lung disease without chest pain;
* No onset of symptoms within last 24 hours;
* No written consensus.
Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

National Health and Family Planning Commission, P.R.China

OTHER_GOV

Sponsor Role collaborator

West China Hospital

OTHER

Sponsor Role collaborator

Xinhua Hospital, Shanghai Jiao Tong University School of Medicine

OTHER

Sponsor Role collaborator

Shanghai Chest Hospital

OTHER

Sponsor Role collaborator

First Affiliated Hospital of Harbin Medical University

OTHER

Sponsor Role collaborator

Second Affiliated Hospital of Xi'an Jiaotong University

OTHER

Sponsor Role collaborator

Henan Provincial People's Hospital

OTHER

Sponsor Role collaborator

Shandong University

OTHER

Sponsor Role collaborator

Yuguo Chen

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Yuguo Chen

President-elect, Chinese Society of Emergency Medicine;Director, Chest Pain Center, Qilu Hospital of Shandong University

Responsibility Role SPONSOR_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Yuguo Chen, M.D., Ph.D.

Role: STUDY_CHAIR

Qilu Hospital of Shandong University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

First Affiliated Hospital of Harbin Medical University

Harbin, Heilongjiang, China

Site Status NOT_YET_RECRUITING

Henan Provincial Hospital

Zhengzhou, Henan, China

Site Status NOT_YET_RECRUITING

Second Affiliated Hospital of Xi'an Jiaotong University

Xi'an, Shaanxi, China

Site Status NOT_YET_RECRUITING

Qilu Hospital of Shandong University

Jinan, Shandong, China

Site Status RECRUITING

Shanghai Chest Hospital

Shanghai, Shanghai Municipality, China

Site Status NOT_YET_RECRUITING

Xinhua Hospital, Shanghai Jiao Tong University School of Medicine

Shanghai, Shanghai Municipality, China

Site Status NOT_YET_RECRUITING

West China Hospital

Chengdu, Sichuan, China

Site Status NOT_YET_RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

China

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Yuguo Chen, M.D., Ph.D.

Role: CONTACT

86-18678812777

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Xiujie Wang, M.D,Ph.D

Role: primary

86-13945690985

Yingjie Chu, M.D,Ph.D

Role: primary

86-13937199780

Honghong Pei, M.D,Ph.D

Role: primary

86-18991237562

Yuguo Chen, M.D., Ph.D.

Role: primary

86-18678812777

Weiyi Fang, M.D,Ph.D

Role: primary

86-13916688508

Shuming Pan, M.D,Ph.D

Role: primary

86-13801612110

Yu Cao, M.D,Ph.D.

Role: primary

86-18980601184

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

ChiCTR-IOQ-14005268

Identifier Type: REGISTRY

Identifier Source: secondary_id

201502032

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.